Tumor Invasiveness and Clinical Outcomes between Metastatic ROS-1 and ALK Positive NSCLC
JOURNAL OF THORACIC ONCOLOGY(2022)
关键词
ROS-1+NSCLC, ALK plus NSCLC, Crizotinib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF THORACIC ONCOLOGY(2022)